Industry Articles

Sponsors will see success in their CDMO partnerships by dedicating time and effort to establish a plan that identifies outsourcing drivers, to select a model that matches company needs and resources, to establish a decision-making process and group, and to…

Highly potent API manufacturing is a rapidly growing segment of drug development. Those familiar with HPAPI understand its specialized nature and the strict regulations surrounding it. A complicated and resource-intensive process, sponsors often find themselves in need of knowledgeable outsourcing…

I bet you can’t say “cell & gene therapies” three times fast. And by the time you do, you’ll have missed another article on your newsfeed discussing their intricacies and the headaches they can cause. Here’s one from Industry Standard…

ISR’s CTMS Benchmarking & Market Dynamics (3rd Ed.) aims to tackle clinical trial management systems (CTMS) by helping providers and sponsors alike better understand current trends surrounding this technology and anticipate future ones. This report is the result of primary…

Hybrid trials. Decentralized trials. Remote trials. Virtual trials. No matter what you (or anyone else) call them, the rapid uptake of trials in which patients participate from home for some visits/activities rather than exclusively in a clinical setting has been…

By Kate Hammeke, VP of Market Research, Industry Standard Research (ISR) @ISRreports For the past six years, Industry Standard Research has asked oral dose outsourcers about the proportions of their projects that are simple, neither simple nor complex, and complex.…

How would you outsource your Phase II/III research needs if you were the only person making the decision? Market Research Director at Industry Standard Research Sherry Hubbard-Bednasz discusses how ISR uses that question to gauge service provider quality and performance.…

Primary market research by ISR Reports is the basis of the awards. Sponsors provide ratings of CROs based on recent outsourced projects. CROs have an opportunity to with these awards in up to three groups of outsourcing respondents – Big…

Over the past year, the pharma industry has been in overdrive. The best of the best around the world – biochemists, scientists, doctors, researchers, and the like – came together to develop a COVID-19 vaccine in record time. Several vaccines…

Market Research Director at Industry Standard Research Sherry Hubbard-Bednasz takes a look at the clinical outsourcing models most preferred by outsourcers, and why those models work best for their proponents. “Let’s say you are sponsoring a novel clinical study that…

Vice President of Market Research at Industry Standard Research Rebecca McAvoy analyzes results from a recent study indicating that COVID-19 has made sponsors more willing to run hybrid trials. “In a November 2020 survey, Industry Standard Research (ISR) asked 121…